Dr. Lia Ana Chebeleu, MD

Dr. Chebeleu practices at Salt Lake Clinic - Mammography in Salt Lake City, Utah.

Dr. Chebeleu's NPI, 1174727739, was assigned on June 14, 2007. Dr. Chebeleu holds Utah license 8039433-1205.

Dr. Chebeleu's primary practice is Salt Lake Clinic - Mammography, at 389 S. 900 E., Salt Lake City, UT 84102. The practice phone is (833) 626-4666.

Dr. Chebeleu's primary practice is Salt Lake Clinic - Mammography in Salt Lake City, Utah. Dr. Chebeleu is also affiliated with LDS Hospital. The medical group on file is Intermountain Health. Dmand AI also links Dr. Chebeleu to 2 more hospitals, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chebeleu practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Chebeleu's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Chebeleu's licenses on file in 2 states: Utah and Texas.

CMS data shows 325 Medicare services from Dr. Chebeleu across 3 procedure codes in 2024, for 92 Medicare patients. Medicare paid $27,401 for them. Every service was in an office.

CMS counts 92 Medicare patients who saw Dr. Chebeleu in 2024. The largest group is 75 to 84, with 43 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 13% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chebeleu's median patient age at 60, with 66% women.

In 2024, Dr. Chebeleu wrote 731 Medicare Part D claims for 134 patients. 91% of them were for generic drugs. CMS names the drug for 622 of them, across 22 drugs with 11 or more claims each, at $54,744 in total drug cost. In 2023, CMS named 436 claims across 17 drugs.

Dr. Chebeleu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chebeleu as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 306 general payments to Dr. Chebeleu from 45 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 42% of the total. Sanofi and Genzyme US Companies paid the most, $3,452.